Race, Ethnicity Appear to Affect Lupus Prognosis in U.S.

This article originally appeared here.
Share this content:
Race, Ethnicity Appear to Affect Lupus Prognosis in U.S.
Race, Ethnicity Appear to Affect Lupus Prognosis in U.S.

(HealthDay News) -- In the United States, Asian and Hispanic patients with systemic lupus erythematosus (SLE) have lower death rates than whites, blacks, or Native Americans with the disease, according to a study published online Jan. 15 in Arthritis & Rheumatology.

Researchers reviewed Medicaid claims filed by 42,221 SLE patients, aged 18 to 65, between 2000 and 2006. Of those patients, 8,191 had lupus nephritis.

By racial/ethnic group, the percentages of patients with SLE or lupus nephritis were: black, 40 percent; white, 38 percent; Hispanic, 15 percent; Asian, 5 percent; and Native American, 2 percent. Hispanic and Asian SLE patients had the lowest death rates. The annual death rate was highest among Native Americans, blacks, and whites, in that order.

"In less than three years of follow-up of Medicaid patients with lupus, we found a great disparity in mortality rates among ethnic groups. Understanding the variation of death among the races is important to determine how best to treat individual patients, modify risk factors, and ultimately improve survival for those with lupus," lead author José Gómez-Puerta, M.D., Ph.D., M.P.H., of Brigham and Women's Hospital in Boston, said in a journal news release.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters


More in Home

Social, Communication Delays With False-Negative on M-CHAT

Social, Communication Delays With False-Negative on M-CHAT

Delays for those who pass M-CHAT screening at 18 months but are later diagnosed with ASD

FDA Approves Aimovig to Prevent Migraines

FDA Approves Aimovig to Prevent Migraines

Patients taking Aimovig reported one to two fewer monthly migraine days than those taking pacebo

Risk of Dementia Up for Older Adults With Lowest Wealth

Risk of Dementia Up for Older Adults With ...

Increased risk seen independent of education, index of multiple deprivation, health indicators

is free, fast, and customized just for you!

Already a member?

Sign In Now »